Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5536458 | Vaccine | 2017 | 5 Pages |
Abstract
Anti-diphtheria antibody levels decrease with aging, and frequent booster vaccinations are required to maintain herd immunity. We analyzed the diphtheria toxin neutralizing antibody (DT-Nab) response induced by a conjugate vaccine (meningococcal C polysaccharide-CRM197) in HIV-vertically infected (HI) children and adolescents and healthy controls (HC) with matched age. We report the association of DT-Nab with the bactericidal antibodies to serogroup C meningococcus (MenC). Before vaccination, 21 HI patients (50%) had no protection against diphtheria (â¤0.01 IU/ml of antibody) and only 8 (19%) showed complete protection (â¥0.1 IU/ml). About half of the HC (56%) had complete protection before immunization and 6 subjects (12%) had no protection against diphtheria. After one and two vaccine injections, 96% of HC and 64% of HI vaccinees, respectively, showed full protection against diphtheria. These data indicate that CRM197 was able to induce primary and/or booster response in both groups of individuals.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Giselle P. Silva, Rafaela S. Santos, Wânia F. Pereira-Manfro, Bianca Ferreira, Daniella M. Barreto, Ana Cristina C. Frota, Cristina B. Hofer, Lucimar G. Milagres,